![]() ![]() AliveCor has been recognized as one of the most promising technology pioneers by the World Economic Forum for accurately recording heart rate and ECG at any place or time. AliveCor was named the No.1 artificial intelligence company in Fast Company’s Top 50 Most Innovative Companies. KardiaMobile provides instant detection of atrial fibrillation, bradycardia, tachycardia, and normal heart rhythm in an ECG. The FDA-cleared KardiaMobile device is the most clinically validated personal ECG solution in the world. is transforming cardiological care using deep learning. Backed up by years of researchĪliveCor, Inc. The device is small enough to fit in a pocket, allowing users to check in on their heart anytime, anywhere right from their smartphone. Medical-grade ECG in just 30 seconds Medical Grade ECGĪliveCor’s innovative technology gives patients the ability to record a medical-grade ECG in just 30 seconds in home. FDA Cleared 6-lead ECG gives your doctor more detailed heart information Provides doctors visibility into certain arrhythmias that are leading indicators of cardiovascular disease. Detects the 3 most common heart arrhythmias: Atrial fibrillation, Bradycardia, Tachycardia. However, its utility for the early detection and diagnosis of arrhythmias in children and patients with a CHD, which have a different normal physiology of the heart rhythm, has not yet been studied.Portable ECG – AliveCor KardiaMobile 6L From the Manufacturer:ĪliveCor’s innovative technology gives patients the ability to record a medical-grade ECG in just 30 seconds in home. The REHARSE-AF study, has demonstrated the efficacy of this device in the early diagnosis of arrhythmic disorders in adults by performing ECGs twice weekly plus additional ECG if symptomatic. The Kardia Mobile Cardiac Monitor is a handheld ECG device that enables users to collect and store single-channel ECG recordings using the smartphone, smartwatch, or tablet. In recent years, technological development has allowed the validation of different tools for detection of arrhythmias by "smart" devices. However, it is an invasive test that is thought to be avoided in children if possible and might be poorly tolerated in patients with CHD. In case of high clinical suspicion, implantable loop-recorder and electrophysiological study can be performed to finally reach a diagnosis. To study the origin of palpitation and syncope 12 lead ECG and 24-hours Holter monitoring is typically performed. In many cases arrhythmia occur earlier in life and sometimes SCD is the first symptom of manifestation. These patients have an overall higher risk of developing cardiac arrhythmias as consequence of the pre-existing anatomical alterations, as well as the surgical treatment necessary for its correction. Syncope and palpitation deserve even higher attention in patients with congenital heart disease (CHD). Sudden cardiac death (SCD) is a rare but devastating event in children and adolescents. The theoretical possibility of an underlying fatal arrhythmia adds remarkable to the mental health challenges of adolescence and the families. Despite considerable testing and expense accurate diagnosis of the underlying cause of syncope is still challenging. ![]() Syncope commonly is of benign character in children but it can be the first warning sign of a serious condition. However, with the current diagnostic tools and protocols in only 10 % to 15 % of children with palpitation an underlying arrhythmia is found. Besides the need for precise diagnosis to choose adequate management and therapy, unrecognized paroxysmal SVT have shown to lead to misdiagnosis mimicking symptoms of a psychiatric disorder. Early onset of atrial fibrillation, for example, in childhood usually reveals a genetic pathology and therefore needs further investigation. Some SVT can be the first manifestation of an underlying heart disease. While some SVTs caused by the presence of an accessory pathway are highly recommend to be treated, other forms of arrhythmia are rarely life threatening and therapy depends on the burden of symptoms. In children with palpitation supraventricular tachycardia (SVT) is the most common final diagnosis. Syncope and palpitation are one of the most common referrals to pediatric cardiology in patients with and without structural heart disease. ![]() Why Should I Register and Submit Results?. ![]()
0 Comments
Leave a Reply. |